Task: Answer the multiple choice question.
Query: Which drug exhibits a -9.070% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC(C)(C)Nc1nc(Oc2ccc(=O)[nH]n2)nc(N2CCOCC2)n1
b CCOc1cccc(N2C(=O)CC(n3cnc4ccccc43)C2=O)c1
Answer: a. CC(C)(C)Nc1nc(Oc2ccc(=O)[nH]n2)nc(N2CCOCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)Nc1nc(Oc2ccc(=O)[nH]n2)nc(N2CCOCC2)n1
CC(C)(C)Nc1nc(Oc2ccc(=O)[nH]n2)nc(N2CCOCC2)n1
3-[[4-(tert-butylamino)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]-1H-pyridazin-6-one